Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

44%

4 of 9 completed trials have results

Key Signals

2 recruiting4 with results

Enrollment Performance

Analytics

N/A
9(75.0%)
Phase 1
3(25.0%)
12Total
N/A(9)
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)